The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 29, 2022

Filed:

Sep. 28, 2018
Applicant:

Merck Patent Gmbh, Darmstadt, DE;

Inventors:

Christoph H. Ladel, Darmstadt, DE;

Hans Guehring, Geisenheim, DE;

Anne-Christine Bay-Jensen, Copenhagen, DK;

Morten Karsdal, Copenhagen, DK;

Per Qvist, Copenhagen, DK;

Assignee:

MERCK PATENT GMBH, Darmstadt, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); G01N 33/68 (2006.01); A61P 19/04 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6887 (2013.01); A61K 38/1825 (2013.01); A61P 19/04 (2018.01); G01N 2333/78 (2013.01); G01N 2800/105 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention relates to biomarkers associated with the clinical response to an FGF-18 compound before or during treatment of a cartilage disorder. The present invention more particularly relates to specific proteins present in the blood, serum, synovial fluid or in the urine, which can be used for the diagnosis and treatment of cartilage disorders. The invention further discloses specific proteins that are related to cartilage response to an FGF-18 compound treatment as well as diagnostic tools and kits based on their expression profile. Thus, the invention can be used in predicting the response to an FGF-18 compound treatment, before starting the treatment with FGF-18 or during the treatment. It could be used for selecting/identifying subjects to be treated by intra-articular administration of an FGF-18 compound. The use of these biomarkers in diagnostics could result in increased benefit and reduced risk in subjects.


Find Patent Forward Citations

Loading…